Medtronic

Boston – October 17, 2026 -- The MedTech Conference (#MTC26) in Boston this October will host its first dedicated gathering for chief medical officers, open to CMOs at AdvaMed member companies, according to Bobby Patrick, AdvaMed's SVP of Government Affairs.

Patient Pavilion carries stories from 13 named medtech companies

The Patient Pavilion in the exhibit hall will anchor the patient programming throughout the week. Patients will share experiences with technologies from Abbott, BD, Dexcom, Edwards Lifesciences, Insulet, Medtronic, Philips, Resmed, Siemens Healthineers, Smith+Nephew, Stryker, Solventum, Vantive and other companies. Attendees can see Philips' portable MRI technology up close.

One featured story involves a patient named Brittany, whose severe sleep apnea diagnosis explained years of exhaustion. Treatment restored her energy, confidence and independence.

Galway – October 07, 2026 -- Medtronic plc has fixed the final exchange ratio for its split-off of MiniMed Group, Inc. at 4.5939 shares of MiniMed common stock for every Medtronic ordinary share tendered and accepted.

Medtronic caps the swap at the upper limit after shares priced above range

The company said the calculated per-share values of both Medtronic ordinary shares and MiniMed common stock, determined under the method set out in MiniMed's SEC-filed Prospectus, would have produced a ratio exceeding the deal's upper limit of 4.5939. Medtronic therefore locked the ratio at that ceiling, the maximum allowed under the offer's terms.

Delray Beach, Fla. – September 28, 2026 -- The global telehealth and telemedicine market is projected to grow from USD 118.8 billion in 2026 to USD 198.9 billion by 2031, expanding at a compound annual growth rate of 10.9%, according to a new report from MarketsandMarkets. A separate figure cited in the same report puts the 2025 market at USD 106.0 billion, underscoring the sector's rapid acceleration ahead of the forecast period.

Delray Beach, Fla. – September 11, 2026 -- The global medical supplies market is projected to grow from $194.76 billion in 2026 to $248.03 billion by 2031, a compound annual growth rate of 7.39%, according to new research from MarketsandMarkets.

Asia Pacific outpaces global growth rate as diagnostic demand accelerates

Asia Pacific is set to register the fastest regional CAGR at 10.2% through 2031, outstripping the global average as healthcare infrastructure expands across the region. By product type, infusion and injectable supplies will grow fastest at a 9.0% CAGR, while diagnostic supplies held the largest share in 2025 and are expected to post the quickest growth of any category over the forecast period, driven by rising chronic and infectious disease burdens and expanding preventive screening programs.

SHERIDAN, WYOMING - March 31, 2026 - European hospitals evaluating 2026 imaging, intervention, and workforce plans now have a new validation pathway for AI-assisted neurovascular and oncology procedures as the SHERPA consortium starts seven clinical studies focused on workflow automation, precision support, and staff-pressure reduction in minimally invasive care. The four-year project has a total budget of EUR 21.5 million, is coordinated by Philips, and is co-funded by the EU Innovative Health Initiative and industry partners. Its work targets minimally invasive treatment workflows for brain aneurysms, liver tumors, and lung biopsy settings where specialized expertise is limited and procedure complexity is high.